Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, October 18, 2017 ) The U.S. Uterine Fibroid Market is growing with the rapid pace; mainly due the burgeoning Healthcare Sector. According to a recent study report published by the Market Research Future, The U.S. Uterine Fibroid Market is booming and expected to gain prominence over the forecast period. U.S. Uterine Fibroid Market Information by Type (Subserosal Fibroids, Intramural Fibroids, Submucosal Fibroids and others), by Diagnosis (Medical Resonance Imaging (MRI) scanners, Computed Tomography (CT), Ultrasounds and others) and Treatment (Uterine Fibroid Embolization, Magnetic Resonance Guided Focused Ultrasound, Myolysis, Endometrial Ablation, Hysterectomy and Myomectomy) - Forecast to 2022 Market Synopsis of U.S. Uterine Fibroid Market: Uterine Fibroids are the abnormal growth that gets developed inside or on the wall of a woman’s uterus. These are also known as leiomyoma or myomas. These are noncancerous growths that cause symptoms such as heavy bleeding between or during the menstrual cycle, pain in pelvis or lower back, increased menstrual cramping, swelling enlargement of the abdomen. Increasing prevalence due to heredity and rising number of treatments to cure this disease has fuelled the growth of this market. Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/2394. The U.S. Market for Uterine Fibroids is expected to reach USD 39,993.2 million by the end of the forecasted period and is expected to grow at a CAGR of 3.24%. Some of the key players in this market are: AstraZeneca (England), Cook Medical Inc. (US), Boston Scientific Corporation (US), GE Healthcare (U.K.), AbbVie Inc. (U.S.), Hologic (U.S.), and others. Segments: U.S. Uterine Fibroid Market has been segmented on the basis of type which comprises of Subserosal Fibroids, Intramural Fibroids, Submucosal Fibroids and others. On the basis of diagnosis the market is segmented into Medical Resonance Imaging (MRI) scanners, Computed tomography (CT), Ultrasounds and others. On the basis of treatment the market is segmented into Uterine Fibroid Embolization, Magnetic Resonance Guided Focused Ultrasound, Myolysis, Endometrial Ablation, Hysterectomy and Myomectomy. Key Finding The U.S. Uterine Fibroid market and is expected to reach USD 39,993.2 million by 2022. By Type, Intramural Fibroids holds the largest market share of U.S. uterine fibroid market and is expected to reach USD 14,972.5 million by 2022. By Treatment, hysterectomy holds the largest market share of U.S. uterine fibroid market and is expected to reach USD 8,042.3 million by 2022. Ask Question to Expert at https://www.marketresearchfuture.com/enquiry/2394 . Study Objectives U.S. Uterine Fibroid Market: To provide detailed analysis of the market structure along with forecast for the next 5 years of the various segments and sub-segments of the U.S. Uterine Fibroid Market To provide insights about factors affecting the market growth To analyze the market based on various factors - price analysis, supply chain analysis, porters five force analysis etc. To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa. To provide country level analysis of the market with respect to the current market size, volume, average selling price and future prospective To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments U.S. Regional Analysis of U.S. Uterine Fibroid Market: The U.S. market for uterine fibroids is growing steadily. The market for uterine fibroids is growing with the CAGR of 3.24% during the forecast period from 2016-2022. California, Texas, Florida, New York are some of the states which are estimated to have highest prevalence of uterine fibroids. About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Contact: Akash Anand, Market Research Future +1 646 845 9312 Email: sales@marketresearchfuture.com
Ask Question to Expert at
Marketresearchfuture
Market Research Future
+1 (646) 845 9349
sales@wiseguyreports.com
Source: EmailWire.Com
Source: EmailWire.com
|
|
|
|